vaccin
develop
first
two
hundr
year
sinc
jenner
lifetim
accomplish
strike
reduct
infect
diseas
wherev
appli
pasteur
earli
approach
vaccin
develop
attenu
inactiv
even
two
pole
vaccin
technolog
today
purif
microbi
element
genet
engin
improv
knowledg
immun
protect
allow
direct
creation
attenu
mutant
express
vaccin
protein
live
vector
purif
even
synthesi
microbi
antigen
induct
varieti
immun
respons
manipul
dna
rna
protein
polysaccharid
noninfecti
infecti
diseas
within
realm
vaccinolog
profus
new
vaccin
enabl
new
popul
target
vaccin
requir
develop
rout
administr
addit
inject
come
new
problem
product
regul
distribut
vaccin
mild
ill
human
could
prevent
smallpox
discoveri
led
erad
smallpox
twentieth
centuri
also
gave
cachet
idea
deliber
protect
exposur
infecti
diseas
histori
vaccin
deliber
endeavor
began
laboratori
loui
pasteur
aphor
chanc
favor
prepar
mind
never
aptli
illustr
discoveri
attenu
pasteur
vacat
summer
return
autumn
studi
chicken
cholera
caus
call
today
pasteurella
multocida
cultur
left
bench
summer
inocul
chicken
caus
diseas
pasteur
made
fresh
cultur
inocul
chicken
whether
parsimoni
purpos
know
case
chicken
resist
fresh
challeng
pasteur
realiz
age
cultur
render
immun
observ
pasteur
construct
hypothesi
pathogen
could
attenu
exposur
environment
insult
high
temperatur
oxygen
chemic
ensu
work
anthrax
rabi
confirm
hypothesi
tabl
outlin
strategi
use
subsequ
develop
live
vaccin
next
centuri
calmett
use
passag
artifici
media
attenu
mycobacterium
bovi
theiler
use
passag
mice
chick
embryo
attenu
yellow
fever
viru
meanwhil
concept
antibodi
cellular
immun
respons
develop
origin
work
paul
ehrlich
ilya
metchnikoff
respect
measur
thereof
rel
primit
method
establish
dual
natur
adapt
immun
system
vaccinologist
consequ
focus
stimul
respons
middl
twentieth
centuri
cell
cultur
adapt
growth
virus
long
realiz
passag
cell
cultur
also
mean
attenu
presum
fortuit
select
mutant
better
adapt
replic
vitro
live
host
cell
cultur
also
permit
consciou
select
mutant
isol
singl
clone
incub
temperatur
normal
temperatur
host
thu
period
saw
develop
numer
attenu
viru
vaccin
includ
polio
sabin
oral
measl
rubella
mump
varicella
import
technolog
applic
virus
segment
genom
reassort
cell
cultur
develop
influenza
rotaviru
vaccin
greatli
aid
abil
mix
rna
segment
attenu
strain
rna
encod
protect
antigen
circul
wild
strain
live
kill
influenza
vaccin
depend
reassort
live
vaccin
contain
replic
reassort
wherea
inactiv
vaccin
produc
live
reassort
seed
two
three
rotaviru
vaccin
develop
far
depend
reassort
contain
gene
human
strain
gene
anim
rotavirus
nonpathogen
human
idea
complet
inactiv
mean
vaccin
develop
also
start
nineteenth
centuri
long
pasteur
origin
insight
prioriti
probabl
goe
daniel
salmon
theobald
smith
unit
state
although
pasteur
team
led
emil
roux
made
independ
discoveri
principl
tabl
outlin
subsequ
strategi
develop
inactiv
vaccin
first
one
direct
typhoid
cholera
bacilli
recent
inactiv
polio
vaccin
salk
type
togeth
oral
vaccin
almost
erad
polio
world
hepat
vaccin
contain
whole
inactiv
virus
recognit
extracellular
bacteri
toxin
roux
yersin
behr
kitasato
permit
develop
toxoid
inactiv
toxin
ramon
diphtheria
tetanu
technolog
advanc
becam
possibl
separ
use
subunit
organ
form
extract
infect
tissu
eg
rabi
capsular
polysaccharid
eg
typhoid
vi
pneumococci
protein
eg
acellular
pertussi
late
twentieth
centuri
conjug
protein
polysaccharid
becam
power
weapon
encapsul
bacteria
eg
haemophilu
influenza
type
b
realiz
infant
would
respond
stimul
b
cell
without
concomit
tcell
stimul
use
peptid
vaccin
slow
need
strong
adjuv
peptid
role
experiment
cancer
vaccin
advent
molecular
biolog
genet
engin
everi
domain
biolog
dramat
effect
vaccin
develop
provid
greater
opportun
construct
inactiv
antigen
ration
attenu
organ
direct
mutat
tabl
list
newer
strategi
depend
molecular
biolog
first
success
genet
engin
hepat
b
vaccin
manufactur
yeast
recombin
carri
gene
protein
replac
vaccin
base
purif
particl
plasma
infect
individu
subsequ
insert
gene
yeast
escherichia
coli
chines
hamster
ovari
cell
enabl
product
varieti
recombin
protein
lyme
ospa
cytomegaloviru
gb
pertussi
toxin
recombin
virus
bacteria
also
may
use
live
vaccin
condit
apathogen
exampl
bovin
attenu
human
parainfluenza
virus
serv
backbon
insert
gene
parainfluenza
virus
respiratori
syncyti
viru
attenu
yellow
fever
viru
serv
carrier
gene
dengu
west
nile
virus
protein
express
insert
gene
immun
term
vector
vaccin
often
use
live
recombin
key
issu
vector
carrier
incorpor
express
gene
pathogen
without
caus
ill
mani
viral
bacteri
vector
propos
favor
poxvirus
adenovirus
bacil
bcg
well
other
employ
effort
develop
hiv
malaria
vaccin
often
primeboost
configur
call
immun
system
prime
protein
express
inject
dna
plasmid
vector
boost
protein
solubl
form
express
anoth
vector
alphaviru
replicon
special
case
vector
replicon
particl
carri
viral
genom
express
foreign
gene
singl
cycl
replic
product
viral
protein
vitro
result
selfassembl
structur
resembl
whole
viru
socal
viruslik
particl
fig
particl
immunogen
solubl
protein
led
highli
effect
papillomaviru
vaccin
vaccin
still
test
human
one
sar
viru
wide
use
technolog
modern
vaccinolog
antigen
discoveri
vaccin
develop
fruit
discoveri
fulli
serendipit
pasteur
bacteri
dna
plasmid
contain
gene
viral
pathogen
would
express
correspond
protein
intramuscular
intraderm
inject
vivo
antigen
thu
produc
carri
bone
marrow
antibodi
cellular
immun
elicit
unfortun
technolog
proven
reliabl
human
although
induct
cellular
immun
frequent
antibodi
nevertheless
dna
plasmid
interest
properti
abil
induc
respons
despit
presenc
passiv
matern
antibodi
still
much
studi
one
particular
applic
dna
plasmid
revers
genet
allow
construct
novel
negativestrand
segment
rna
virus
mutat
cdna
introduct
multipl
cdna
plasmid
contain
entir
viral
genom
cell
cultur
togeth
plasmid
express
enzym
reconstitut
viru
techniqu
current
incorpor
manufactur
influenza
vaccin
allow
exampl
rapid
product
seed
viru
avian
influenza
vaccin
fear
viru
adapt
human
abil
sequenc
microbi
genom
permit
identif
new
protect
factor
predict
gene
nucleotid
sequenc
express
e
coli
result
protein
use
immun
mice
antibodi
produc
organ
interest
especi
bactericid
neutral
antibodi
protect
wide
rang
strain
protein
becom
interest
develop
process
call
revers
vaccinolog
similarli
microarray
analysi
use
identifi
microbi
gene
turn
invas
infect
thu
protein
may
virul
factor
counter
prior
immun
must
admit
recent
immunolog
contribut
much
develop
vaccin
emphas
accompani
articl
success
immun
mediat
induct
protect
antibodi
wherea
major
challeng
face
us
eg
hiv
malaria
tuberculosi
requir
induct
cell
immun
well
fortun
sever
new
strategi
includ
vector
plasmid
dna
lipid
peptid
capabl
induc
cellular
respons
addit
pauciti
adjuv
vaccin
recent
essenti
limit
aluminum
salt
stimul
helper
type
h
respons
last
correct
creation
new
oilinwat
emuls
liposom
tolllik
receptor
agonist
cytokin
substanc
push
immun
system
helper
type
h
direct
moreov
immunologist
recent
provid
us
test
cellular
immun
done
larg
scale
elispot
assay
cytokin
induct
tetram
stain
cell
peptid
specif
recent
rediscoveri
regulatori
cell
may
also
impact
vaccin
pathogen
tri
evad
immun
system
earli
day
twentyfirst
centuri
one
descri
sever
notabl
tendenc
vaccin
develop
combin
vaccin
becom
ever
necessari
new
compon
becom
part
routin
vaccin
alreadi
hexaval
combin
contain
diphtheria
tetanu
pertussi
h
influenza
type
b
hib
hepat
b
inactiv
polio
vaccin
use
europ
pentaval
combin
mani
part
world
varicella
vaccin
incorpor
measlesmumpsrubella
vaccin
variou
combin
h
influenza
type
b
pneumococc
meningococc
conjug
bacteri
polysaccharid
vaccin
becom
avail
anoth
easili
discern
tendenc
toward
stimul
innat
well
adapt
immun
respons
accomplish
choic
proper
adjuv
cpg
oligonucleotid
stimul
type
respons
proteom
probabl
advanc
point
allow
construct
vitro
protein
natur
conform
polysaccharid
synthesi
begin
practic
wherea
vaccin
usual
consid
prophylaxi
seriou
attempt
made
develop
therapeut
vaccin
chronic
infect
basic
idea
induc
cellular
immun
respons
suppress
infect
even
host
unabl
mount
respons
natur
exampl
includ
immun
oncogen
papillomavirus
treatment
cervic
cancer
gag
tat
gene
hiv
suppress
viral
replic
aid
import
part
futur
enlarg
rout
immun
tabl
vaccin
today
given
parenter
inject
induc
system
immun
respons
express
b
cell
blood
need
mucos
immun
respons
becom
increasingli
obviou
new
live
attenu
influenza
vaccin
given
intranas
induc
system
local
respons
give
broader
protect
antigen
drift
strain
aerosol
administr
measl
rubella
vaccin
implant
attenu
virus
natur
site
replic
elicit
immun
equival
inject
aerosol
rout
could
lend
mass
immun
use
inhal
devic
oral
immun
use
time
immun
live
organ
replic
intestin
oral
polio
typhoid
vaccin
attempt
made
induc
mucos
respons
nonliv
antigen
one
approach
develop
oral
vaccin
plant
made
transgen
vaccin
antigen
demonstr
adequ
immun
respons
human
await
immun
rectal
vagin
applic
antigen
also
investig
closest
actual
use
vaccin
transderm
applic
mani
devic
develop
deliv
antigen
across
skin
includ
patch
contain
adjuv
appli
lightli
abrad
skin
microneedl
pierc
stratum
corneum
figur
show
one
microneedl
devic
past
superfici
layer
antigen
come
contact
dendrit
antigenpres
cell
travel
lymph
node
initi
immun
respons
transderm
immun
work
well
vaccin
practic
could
revolution
activ
immun
heretofor
larg
confin
infecti
diseas
use
desensit
treat
allergi
consider
given
immun
wide
varieti
noninfecti
diseas
effort
direct
cancer
novel
cellular
antigen
often
present
vaccin
incorpor
protein
peptid
cancer
antigen
advanc
trial
promis
result
measur
prolong
life
also
intrigu
individu
inherit
mutat
predispos
cancer
might
immun
prophylact
cancer
develop
toler
autoantigen
attempt
mani
autoimmun
diseas
multipl
sclerosi
diabet
mellitu
better
antigen
induc
igg
rather
ige
antibodi
allergen
develop
contracept
maintain
immun
hormon
atherosclerosi
alzheim
diseas
perhap
control
immun
cholesterol
fraction
amyloid
respect
lastli
drug
addict
includ
nicotin
methamphetamin
cocain
may
control
induc
antibodi
rapidli
remov
drug
bodi
new
popul
target
vaccin
summar
tabl
vaccin
direct
infant
children
becom
increasingli
clear
adolesc
adult
also
need
univers
immun
asid
new
recommend
booster
immun
diphtheriatetanusacellular
pertussi
vaccin
possibl
incorpor
vaccin
meningococci
papillomavirus
herp
simplex
cytomegaloviru
routin
vaccin
requir
adolesc
immun
date
prevent
respect
sepsi
cervic
cancer
genit
herp
congenit
infect
adult
current
receiv
influenza
pneumococc
vaccin
vaccin
may
also
come
play
varicella
viru
prevent
reactiv
form
zoster
also
cours
live
adult
may
need
vaccin
pregnanc
hospit
travel
experiment
group
b
streptococc
vaccin
avail
prevent
transmiss
bacteria
mother
neonat
pregnant
women
could
immun
number
pathogen
eg
pneumococci
respiratori
syncyti
viru
order
transmit
protect
antibodi
protect
newborn
month
antibioticresist
nosocomi
bacteria
increas
problem
staphylococc
capsular
polysaccharid
vaccin
later
stage
develop
patient
suscept
secondari
infect
although
bioterror
unpleas
think
augment
financi
support
stimul
develop
new
vaccin
anthrax
plagu
smallpox
name
case
anthrax
plagu
purifi
antigen
afford
better
protect
safeti
wherea
poxviru
research
gener
attenu
strain
vaccinia
protect
smallpox
prospect
control
diseas
vaccin
thu
quit
bright
must
admit
sever
problem
loom
larg
darken
pictur
first
vaccin
suppli
insuffici
even
industri
countri
shortag
vaccin
occur
manufactur
regulatori
pressur
render
product
ever
difficult
event
emerg
influenza
pandem
difficult
see
demand
could
satisfi
access
provid
develop
countri
growth
new
manufactur
develop
countri
like
india
china
indonesia
brazil
may
fill
gap
solut
suppli
shortag
yet
clear
cost
vaccin
also
problem
new
vaccin
requir
million
develop
compani
research
develop
must
recoup
cost
vaccin
appli
broadli
throughout
world
sever
circumst
must
maintain
higher
price
develop
countri
recognit
govern
financi
save
vaccin
justifi
expenditur
buy
vaccin
support
donor
agenc
vaccin
purchas
poor
countri
vaccin
target
one
concern
develop
countri
problem
becom
even
difficult
support
bill
melinda
gate
foundat
develop
vaccin
target
crucial
certain
point
industri
manufactur
necessari
requir
vaccin
product
facil
outsid
develop
countri
subsid
facil
major
manufactur
grow
demand
vaccin
safeti
fuel
part
antivaccin
group
diseas
reced
need
vaccin
becom
less
evid
public
peopl
opt
social
contract
vaccin
depend
instead
herd
immun
surround
vaccin
person
cours
herd
immun
fail
mani
refus
vaccin
real
safeti
problem
associ
vaccin
paralysi
oral
polio
vaccin
dissemin
infect
bacil
reason
older
vaccin
need
reexamin
see
whether
safeti
improv
done
replac
wholecel
pertussi
vaccin
acellular
pertussi
vaccin
replac
rabi
vaccin
made
brain
vaccin
made
cell
cultur
near
futur
jenner
vaccinia
replac
attenu
vaccinia
bacil
engin
vaccin
tuberculosi
inde
one
advantag
newer
molecular
technolog
improv
safeti
riskbenefit
ratio
becom
controversi
diseas
presenc
declin
import
reduc
vaccineassoci
reaction
minimum
hand
zero
risk
imposs
attain
alway
tension
need
public
health
regulatori
impuls
guard
even
remot
theoret
risk
latter
tendenc
act
brake
rapid
applic
new
public
health
measur
thu
disagr
whether
err
side
safeti
diseas
prevent
vaccin
key
tool
mainten
public
health
govern
major
role
dissemin
recommend
purchas
although
government
agenc
particularli
us
nation
institut
health
importantli
support
basic
research
provid
candid
vaccin
direct
involv
industri
develop
product
decreas
doubtless
effici
industri
take
vaccin
concept
licens
govern
advis
choic
target
vaccin
develop
guarante
market
product
develop
request
moreov
becom
obviou
govern
must
proactiv
prevent
vaccin
shortag
induc
multipl
supplier
mani
diseas
yet
uncontrol
vaccin
new
diseas
sure
emerg
evolut
mutat
gene
exchang
interspeci
transfer
human
exposur
new
environ
fortun
mani
new
tool
produc
protect
antigen
two
hundr
year
research
enabl
us
turn
immun
system
advantag
increas
understand
microbi
pathogenesi
host
respons
allow
us
extend
control
diseas
vaccin
